The findings offer previously undocumented insights into the epigenetic regulation of NK cell-mediated cytotoxicity and pave the way for the translation of EHMT2 and TGF-β1-targeted therapies alone or in combination with other cancer immunotherapeutic agents for cancer treatment in the clinic. This evidence concerns the gene EHMT2 and cancer.